[go: up one dir, main page]

FI884691A0 - Lysostafiinia koodittava DNA-fragmentti, sitä sisältävä yhdistelmäplasmidi ja transformoitu bakteeri sekä menetelmä lysostafiiniaktiivisuuden omaavan tuotteen valmistamiseksi - Google Patents

Lysostafiinia koodittava DNA-fragmentti, sitä sisältävä yhdistelmäplasmidi ja transformoitu bakteeri sekä menetelmä lysostafiiniaktiivisuuden omaavan tuotteen valmistamiseksi

Info

Publication number
FI884691A0
FI884691A0 FI884691A FI884691A FI884691A0 FI 884691 A0 FI884691 A0 FI 884691A0 FI 884691 A FI884691 A FI 884691A FI 884691 A FI884691 A FI 884691A FI 884691 A0 FI884691 A0 FI 884691A0
Authority
FI
Finland
Prior art keywords
lysostaphin
pjp1
dna fragment
provides
transformed
Prior art date
Application number
FI884691A
Other languages
English (en)
Swedish (sv)
Other versions
FI96322B (fi
FI884691A (fi
FI96322C (fi
Inventor
Paul A Recsei
Original Assignee
New York Health Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York Health Res Inst filed Critical New York Health Res Inst
Publication of FI884691A0 publication Critical patent/FI884691A0/fi
Publication of FI884691A publication Critical patent/FI884691A/fi
Publication of FI96322B publication Critical patent/FI96322B/fi
Application granted granted Critical
Publication of FI96322C publication Critical patent/FI96322C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
FI884691A 1986-04-16 1988-10-12 Lysostafiinia koodittava DNA-fragmentti, sitä sisältävä yhdistelmäplasmidi ja transformoitu bakteeri sekä menetelmä lysostafiiniaktiivisuuden omaavan tuotteen valmistamiseksi FI96322C (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US85240786A 1986-04-16 1986-04-16
US85240786 1986-04-16
US3446487 1987-04-10
US07/034,464 US4931390A (en) 1986-04-16 1987-04-10 Expression of the cloned lysostaphin gene
PCT/US1987/000873 WO1987006264A1 (en) 1986-04-16 1987-04-15 Expression of the cloned lysostaphin gene
US8700873 1987-04-15

Publications (4)

Publication Number Publication Date
FI884691A0 true FI884691A0 (fi) 1988-10-12
FI884691A FI884691A (fi) 1988-10-12
FI96322B FI96322B (fi) 1996-02-29
FI96322C FI96322C (fi) 1996-06-10

Family

ID=26710985

Family Applications (1)

Application Number Title Priority Date Filing Date
FI884691A FI96322C (fi) 1986-04-16 1988-10-12 Lysostafiinia koodittava DNA-fragmentti, sitä sisältävä yhdistelmäplasmidi ja transformoitu bakteeri sekä menetelmä lysostafiiniaktiivisuuden omaavan tuotteen valmistamiseksi

Country Status (15)

Country Link
US (1) US4931390A (fi)
EP (1) EP0299978B1 (fi)
JP (1) JP2963695B2 (fi)
AT (1) ATE92524T1 (fi)
AU (1) AU616379B2 (fi)
CA (1) CA1297051C (fi)
DE (1) DE3786918T2 (fi)
DK (1) DK174941B1 (fi)
FI (1) FI96322C (fi)
HU (1) HU205386B (fi)
IE (1) IE60769B1 (fi)
IL (1) IL82260A (fi)
NZ (1) NZ219998A (fi)
PT (1) PT84705B (fi)
WO (1) WO1987006264A1 (fi)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260212A (en) * 1987-02-09 1993-11-09 Quest International Flavors & Food Ingredients Co., Division Of Indopco Cloned gene encoding for bacteriocin from Pediococcus acidilactici
US5858962A (en) * 1987-05-11 1999-01-12 Ambi Inc. Composition for treating mastitis and other staphylococcal infections
US5011772A (en) * 1988-02-05 1991-04-30 Public Health Research Institute Of The City Of N.Y. High yield protein production system
HUT53154A (en) * 1988-05-05 1990-09-28 New York Health Res Inst Process for producing protease-defective gram-positive bacteria and utilizing them as host-organizmus for producing recombinant products
CA2009336A1 (en) * 1989-07-03 1991-01-03 Peter A. Vandenbergh Cloned gene encoding for bacteriocin from pediococcus acidilactici
DE4425645A1 (de) * 1994-07-20 1996-02-22 Mueller Karl & Co Kg Deletiertes Lysostaphingen von Staphylococcus simulans
CZ290578B6 (cs) * 1995-06-23 2002-08-14 Ambi Inc. Léčivo určené k léčbě infekce způsobené multidrogově-rezistentními kmeny stafylokoka, streptokoka nebo enterokoka
WO1997008553A1 (en) * 1995-08-22 1997-03-06 The Regents Of The University Of California Targeting of proteins to the cell wall of gram-positive bacteria
US5910479A (en) * 1996-10-18 1999-06-08 Ambi Inc. Method for the treatment of Streptococcus pneumoniae infection
US6028051A (en) * 1997-07-23 2000-02-22 Ambi Inc. Method for the treatment of staphylococcal disease
US6875903B2 (en) * 1998-06-22 2005-04-05 University Of Vermont Treatment of Staphylococcus infections
AU4706799A (en) * 1998-06-22 2000-01-10 University Of Vermont And State Agricultural College, The Treatment of (staphylococcus) infections
US7091332B1 (en) 1998-06-22 2006-08-15 University Of Vermont Treatment of staphylococcus infections
JP4416866B2 (ja) * 1998-07-30 2010-02-17 オリエンタル酵母工業株式会社 カルシウム測定用液状試薬
US6569830B1 (en) 1999-03-05 2003-05-27 Ambi, Inc. Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains
US6897041B1 (en) * 1999-10-19 2005-05-24 Bharat Biotech International Limited Expression of recombinant mature lysostaphin
AU2002367820B2 (en) * 2001-12-21 2007-11-01 Biosynexus Incorporated Truncated lysostaphin molecule with enhanced staphylolytic activity
US7452533B2 (en) * 2002-03-26 2008-11-18 Biosynexus Incorporated Antimicrobial polymer conjugate containing lysostaphin and polyethylene glycol
CN1642496A (zh) * 2002-03-26 2005-07-20 拜奥辛尼克休斯公司 细菌生物薄膜的酶破坏
US20100221237A1 (en) * 2003-03-26 2010-09-02 Biosynexus Incorporated Enzyme disruption of bacterial biofilms
CN100457794C (zh) 2003-03-28 2009-02-04 三井化学株式会社 丙烯共聚物,聚丙烯组合物及其用途,过渡金属化合物和烯烃聚合催化剂
CN100485031C (zh) * 2004-09-02 2009-05-06 上海高科联合生物技术研发有限公司 一种溶葡萄球菌酶工业化纯化工艺
EP1885403B1 (en) 2005-04-12 2013-05-08 Nektar Therapeutics Poly(ethyleneglycol) conjugates of Lysostaphin
CN100475965C (zh) 2005-07-22 2009-04-08 上海高科联合生物技术研发有限公司 一种大肠杆菌高效外分泌表达溶葡萄球菌酶的方法
US20080095756A1 (en) * 2006-09-05 2008-04-24 Biosynexus Incorporated Compositions Comprising Lysostaphin Variants And Methods Of Using The Same
AU2008273946A1 (en) * 2007-07-09 2009-01-15 Microsens Medtech Limited Detection of micro-organisms based on their NAD-dependent DNA ligase activity
WO2009114520A2 (en) * 2008-03-10 2009-09-17 Pharmain Corporation Compositions for treatment with metallopeptidases, methods of making and using the same
US10041061B2 (en) 2010-09-29 2018-08-07 Ibis Biosciences, Inc. Fungal nucleic acid extraction
US11155801B2 (en) * 2013-08-06 2021-10-26 Trustees Of Dartmouth College Unglycosylated lysostaphin variant protein
EP3086805B1 (en) 2013-12-28 2018-10-03 Longhorn Vaccines and Diagnostics, LLC Use of glycyl-glycine endopeptidase for treating mycobacteria infections
CA2948864C (en) 2014-05-14 2023-10-17 Karl E. Griswold Deimmunized lysostaphin and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278378A (en) * 1962-04-19 1966-10-11 Schindler Charles Alvin Staphylococcus-derived antibiotic
US4467036A (en) * 1981-11-12 1984-08-21 The Board Of Regents Of The University Of Washington Bacillus thuringiensis crystal protein in Escherichia coli
US4617266A (en) * 1983-04-28 1986-10-14 Genex Corporation Production of Protein A

Also Published As

Publication number Publication date
DK174941B1 (da) 2004-03-08
DK659287D0 (da) 1987-12-15
EP0299978A1 (en) 1989-01-25
DE3786918D1 (de) 1993-09-09
FI96322B (fi) 1996-02-29
ATE92524T1 (de) 1993-08-15
DK659287A (da) 1987-12-15
AU7302187A (en) 1987-11-09
IL82260A0 (en) 1987-10-30
IE60769B1 (en) 1994-08-10
WO1987006264A1 (en) 1987-10-22
US4931390A (en) 1990-06-05
JP2963695B2 (ja) 1999-10-18
NZ219998A (en) 1991-05-28
CA1297051C (en) 1992-03-10
EP0299978B1 (en) 1993-08-04
IE870980L (en) 1987-10-16
IL82260A (en) 1992-08-18
DE3786918T2 (de) 1993-11-11
FI884691A (fi) 1988-10-12
PT84705B (pt) 1989-11-30
AU616379B2 (en) 1991-10-31
HU205386B (en) 1992-04-28
HUT50874A (en) 1990-03-28
FI96322C (fi) 1996-06-10
JPH01503036A (ja) 1989-10-19
PT84705A (en) 1987-05-01

Similar Documents

Publication Publication Date Title
FI884691A0 (fi) Lysostafiinia koodittava DNA-fragmentti, sitä sisältävä yhdistelmäplasmidi ja transformoitu bakteeri sekä menetelmä lysostafiiniaktiivisuuden omaavan tuotteen valmistamiseksi
FR2646437B1 (fr) Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
HUT47153A (en) Process for producing recombinant dna sequence encoding human proapolypoprotein a-i, expression vector comprising it, as well as human proapolypoprotein a-i by applying same
GR3030778T3 (en) Expression of recombinant proteins in attenuated bacteria
EP0192741A4 (en) TOXIN SEGMENT OF THE -i CRYSTAL PROTEIN GENE (BACILLUS THURINGIENSIS).
Nomura et al. Carboxy terminal region of haemolysin of Aeromonas sobria triggers dimerization
Lemma et al. Properties of the menaquinol oxidase (Qox) and of qox deletion mutants of Bacillus subtilis
FR2556365B1 (fr) Vecteurs de clonage et d'expression de l'interferon-g, bacteries transformees et procede de preparation de l'interferon-g
EP0200417A3 (en) Production of protein
IL81886A (en) Bacillus thuringiensis insecticidal proteinaceous substance,dna encoding it,its preparation and its use

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: APPLIED MICROBIOLOGY, INC.

MA Patent expired